Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Shire plc | dp65302_8k.htm |
| EX-3.1 - EXHIBIT 3.1 - Shire plc | dp65302_ex0301.htm |
| EX-99.1 - EXHIBIT 99.1 - Shire plc | dp65302_ex9901.htm |
EXHIBIT 99.2
|
Press Release www.shire.com |
 |
Directorate change
April 28, 2016 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”) announces that Olivier Bohuon, Non-Executive Director of the Company, has been appointed as a member of the Remuneration Committee with immediate effect.
Oliver Strawbridge
Senior Assistant Company Secretary
For further information please contact:
| Investor Relations | ||
| Sarah Elton-Farr | seltonfarr@shire.com | +44 1256 894157 |
NOTES TO EDITORS
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.
We focus on providing treatments in Rare Diseases, Neuroscience, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmics.
www.shire.com
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX